
The use of zzso in prostate cancer management is controversial and current guidelines zzso its zzso zzso advances over the past 5 years, however, demand a zzso of this zzso In this article, we propose an increased use of zzso not only in those with a diagnosis of prostate cancer but also for men before a prostate zzso The use of zzso before a biopsy can serve as a zzso test in men with raised serum zzso zzso levels, in order to select those for biopsy with significant cancer that requires zzso This strategy could avoid zzso and hence unnecessary treatment, in those with no disease or insignificant zzso In addition, avoidance of zzso artifact caused by zzso will lead to better local staging zzso while determining more accurately the disease zzso This approach could improve risk zzso by selecting those who require zzso therapy or dose zzso Furthermore, zzso evaluation of cancer burden could be important in active surveillance regimens to select those needing zzso 

